Latest Breaking News On - Welldoc bluestar - Page 1 : comparemela.com

Guest column: With FDA approval of software treatment for depression, the digital medicine revolution is here

Guest column: With FDA approval of software treatment for depression, the digital medicine revolution is here
wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.

United statesWelldoc bluestarLandscape of digital health technologies sourceDtx allianceCareyaya health technologiesPropeller healthBoston university school of public healthOtsuka pharmaceuticalsMental health awareness monthClick therapeuticsWhere digital therapeutics fitDigital health technologiesBoston university schoolPublic healthNature digital medicineEmotional faces memory task

FDA Clears New Capabilities for Diabetes App BlueStar

The app-based system can now make insulin dose recommendations based on continuous glucose monitor (CGM) data.

United statesWelldoc bluestarFeinberg school of medicine at northwestern universityDrug administrationGrazia aleppoFeinberg schoolNorthwestern universityContinuous glucose monitoring cgmDiabetes mellitus type 1Iabetes mellitus type iType 1 diabetesWashington dc district of columbiaUs food and drug administrationNited states food and drug administrationDiabetes mellitus type 2Iabetes mellitus type ii

Prescription Digital Therapeutics (PDTx) Market to Observe Prominent CAGR Growth of 20 35% by 2030

Global Prescription Digital Therapeutics (PDTx) Market report offers advanced information and scenario about the HELATH industry which helps to stand apart in the competition in this fast paced business environment. An influential market report gives methodical idea about the current scenario of the global market, r.

South africaHong kongUnited kingdomSouth koreaSaudi arabiaUnited statesWelldoc bluestarAsia pacificPdtx marketreportBrowse the summary of researchClick therapeutics incSoftware for diabetesHitrust health information trust allianceSoftware for respiratory conditionsSingapore health science authorityMovement disorder

Astellas and Roche Diabetes Care Japan ink partnership agreement to develop and commercialize integrated diabetes self-management solution with BlueStar®

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that it has entered into an agreement.

Kenji yasukawaNoriko hattoriKevin mcraithWelldoc bluestarNaoki okamuraDigital health applicationAstellas pharma incMinistry of healthWelldoc incNational healthRoche diabetes care japan co ltdDrug administrationPrnewswire astellas pharma incCountry managerDiabetes careRoche diabetes care

Astellas, Roche To Develop Integrated Diabetes Self-management Solution With BlueStar

(RTTNews) - Astellas Pharma Inc. said that it has reached an agreement with Roche Diabetes Care Japan Co., Ltd. for the development and commercial.

Welldoc bluestarRoche diabetes care japan co ltdWelldoc incAstellas pharma incMore such health newsRoche diabetes care